Navigation Links
Update: 50 percent of patients in Cedars-Sinai brain cancer study alive after 5 years
Date:11/23/2013

LOS ANGELES (NOV. 23, 2013) Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors glioblastoma multiforme survived longer than five years after diagnosis, according to Cedars-Sinai researchers, who presented findings Nov. 23 at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology.

Seven of the 16 participants still are living, with length of survival ranging from 60.7 to 82.7 months after diagnosis. Six of the patients also were "progression free" for more than five years, meaning the tumors did not return or require more treatment during that time. Four participants still remain free of disease with good quality of life at lengths ranging from 65.1 to 82.7 months following diagnosis. One patient who remained free of brain cancer for five years died of leukemia.

The original clinical trial a Phase I study designed to evaluate safety included 16 patients with glioblastoma multiforme enrolled between May 2007 and January 2010 by researchers at Cedars-Sinai's Johnnie L. Cochran, Jr. Brain Tumor Center.

Results published in January at the end of the study showed median overall survival of 38.4 months. Typically, when tumor-removal surgery is followed by standard care, which includes radiation and chemotherapy, median length of survival is about 15 months. Median progression-free survival the time from treatment to tumor recurrence was 16.9 months at study's end. With standard care, the median is about seven months.

The experimental treatment consists of a vaccine, ICT-107, intended to alert the immune system to the existence of cancer cells and activate a tumor-killing response. It targets six antigens involved in the development of glioblastoma cells.

According to information presented at the scientific meetings, all eight long-term survivors had tumors with at least five antigens, 75 percent had tu
'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
2. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
3. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
4. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
5. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
6. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
7. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
8. Research update: Chemists find help from nature in fighting cancer
9. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
10. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
11. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... new studies further confirm the health benefits of breast-feeding. ... a lower risk of ear, throat and sinus infections ... similar trend when it comes to allergies. The ... immediate newborn period," said Dr. Jennifer Wu, an obstetrician-gynecologist ... was not involved in the new studies. The ...
(Date:9/2/2014)... (HealthDay News) -- Drinking and marijuana may lead to ... study suggests. Researchers analyzed 2007 to 2011 data ... who said they had used alcohol or marijuana at ... was associated with more unsafe driving, damage to relationships ... while under the influence of alcohol, especially among females. ...
(Date:9/2/2014)... York (PRWEB) September 02, 2014 ... with products and services such as anti-wrinkle treatments ... frequency-device based treatments, and breast augmentation becoming much ... published by U.S.-based market intelligence firm Transparency Market ... and products will grow to USD 191.7 billion ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Ticket Down ... The first week in September will be an exciting ... from Brazil, Colombia, Mexico, Chile, Ecuador and Bolivia will battle ... matches will take place between September 5th - September 9th: ... on Tuesday, September 9th , Mexico vs. Chile Tickets ...
(Date:9/2/2014)... California, San Diego School of Medicine have identified an ... The findings, reported in the current issue of PNAS, ... mortality worldwide. An estimated 40,000 women in America will ... American Cancer Society. , "The take-home message of the ... target breast cancer metastasis through a pathway regulated by ...
Breaking Medicine News(10 mins):Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2Health News:Booze, Pot Bad for Teens in Different Ways, Study Suggests 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 3Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3Health News:Enzyme controlling metastasis of breast cancer identified 2
... , ... in their missions for healthy pregnancies, Reproductive Medicine Associates of Connecticut (RMACT) sponsored this ... Fairfield, CT. , ... Norwalk, CT (PRWEB) April 25, 2010 -- Finding synergy in their missions for healthy ...
... freelance journalist and Director of Straight Statistics, a campaign for ... that patients are allocated diagnostic codes by a hospital can ... It follows two articles published by the BMJ ... performance is a bad idea. It began, says Hawkes, ...
... , ... International Fitness Superstar, Jennifer Nicole Lee, will be making a special celebrity appearance ... on HSN, Item #443-777. Based off of her #1 Global Hit, the Ab ... of the Ab Circle Pro, but you get all of the same results. ...
... ... Pharmacy’s “Value and Values” -- Announces NACDS Foundation’s $150,000 Contribution to Assist the Haitian ... Palm ... ( NACDS ) demonstrates value to member companies and improves public policy by communicating ...
... ... , ... (PRWEB) April 25, 2010 -- CureMD Corporation, the leading provider of web based electronic ... CureMD EHR V10 has earned its designation as a fully CCHIT Certified® 2011 Ambulatory ...
... develop skin cancer, experts say , SUNDAY, April ... time to remind teens about the importance of sun ... increase your risk of skin cancer. As few as ... Dr. Anjali Dahiya, a dermatologist at the Iris Cantor ...
Cached Medicine News:Health News:Fertility Clinic Shows Support for Healthy Pregnancies By Sponsoring March of Dimes "March for Babies" 2Health News:Fertility Clinic Shows Support for Healthy Pregnancies By Sponsoring March of Dimes "March for Babies" 3Health News:Is patient coding making hospitals appear better than they are? 2Health News:Global Premiere: Jennifer Nicole Lee, Super Fitness Model & Mega Brand, Reveals Ab Circle Mini on HSN's World Launch 2Health News:Global Premiere: Jennifer Nicole Lee, Super Fitness Model & Mega Brand, Reveals Ab Circle Mini on HSN's World Launch 3Health News:NACDS' Anderson Says Retailers and Suppliers' “Health and Wellness Renaissance” is Creating a “Historic, Watershed Moment” 2Health News:NACDS' Anderson Says Retailers and Suppliers' “Health and Wellness Renaissance” is Creating a “Historic, Watershed Moment” 3Health News:NACDS' Anderson Says Retailers and Suppliers' “Health and Wellness Renaissance” is Creating a “Historic, Watershed Moment” 4Health News:CureMD EHR V10 CCHIT Certified 2011with Five Stars for Usability 2Health News:Time to Remind Teens About Sun Protection 2
(Date:9/2/2014)...   Santa Clara dentist , Dr. Alan ... Invisalign. Invisalign is an orthodontic system that uses clear ... the orthodontic treatment of choice for older teens and ... For a limited time, patients can try Invisalign for ... usual cost. This offer cannot be combined, and some ...
(Date:9/2/2014)... DALLAS , September 2, 2014 ... Chromatography Column Market by Type (Empty, Pre-packed, Analytical, Preparative), by Material ... Flash Chromatography, UFLC), TLC,SFC] - Forecast to 2018", published by ... Million in 2013. It is poised to grow at ... Million by 2018. Browse 90 market ...
(Date:9/2/2014)... Spain , September 2, 2014 ... decisions, including patients, quality of life and treatment satisfaction ... 2 ]   ... ESC Congress 2014, 02 September 2014, Barcelona, ... results of the PREvention oF thromboembolic events-European Registry in ...
Breaking Medicine Technology:Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
Key periosteal elevators, blade width 1" (25 mm), total length 7 1/2" (191 mm)....
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Lederer periosteal elevators....
Medicine Products: